Browse by People

Millward, Christopher P ORCID: 0000-0001-7727-1157, Brodbelt, Andrew R, Haylock, Brian, Husband, David, Shenoy, Aditya, Wong, Helen and Jenkinson, Michael D ORCID: 0000-0003-4587-2139 (2015) THE IMPACT OF MGMT METHYLATION AND IDH-1 MUTATION ON LONG TERM OUTCOME FOR GLIOBLASTOMA TREATED WITH CHEMORADIOTHERAPY. , Austria.

Collapse authors list.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Bagust, Adrian ORCID: 0000-0002-2142-5767, Richardson, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Duarte, Rui et al (show 1 more authors) and Shenoy, Aditya (2020) Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 24 (2). 1-+.

Kinshuck, Andrew J, Shenoy, Aditya and Jones, Terry M (2017) Voice outcomes for early laryngeal cancer. CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 25 (3). pp. 211-216.

Millward, Christopher P ORCID: 0000-0001-7727-1157, Brodbelt, Andrew R, Haylock, Brian, Zakaria, Rasheed ORCID: 0000-0001-6826-2662, Baborie, Atik, Crooks, Daniel, Husband, David, Shenoy, Aditya, Wong, Helen and Jenkinson, Michael D ORCID: 0000-0003-4587-2139 (2016) The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy. ACTA NEUROCHIRURGICA, 158 (10). pp. 1943-1953.

Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Duarte, Rui and Shenoy, Aditya (2019) A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine. BMC CANCER, 19 (1). 1209-.